Experts envision greater cardiac imaging role for PET

03/5/2013 | MolecularImaging.net

PET is gaining momentum as an effective and preferred approach over SPECT for myocardial perfusion imaging in diagnosing coronary artery disease, thanks to improved resolution and other factors. However, experts say there are barriers to the use of PET in routine clinical practice, including pre-approval requirements, which could reduce access to testing. "We may be placing very high barriers for people to get access to some tests that are quite appropriate," said Dr. Marcelo Di Carli, chief of nuclear medicine and molecular imaging at Boston's Brigham and Women's Hospital. "While you are improving appropriateness, you also are reducing access for patients who need these studies.”

View Full Article in:

MolecularImaging.net

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC